Attorney General Steve Marshall has announced that the Cullman County Circuit Court granted his office’s request for a temporary restraining order against Aurora IV and Wellness, an IV infusion clinic in Cullman, and its owners, Amanda and Chris Medders. The court order temporarily closes the business and freezes its assets following allegations of administering unsafe, research-grade weight loss drugs to patients without their knowledge or consent.
According to the complaint filed by the Attorney General’s Office, Aurora IV and Wellness advertised GLP-1 medications tirzepatide and semaglutide as “pharmaceutical-grade” products. However, the complaint states that patients were injected with research-grade versions of these drugs that are not approved for human use. The manufacturer of these substances specifies they are intended only for laboratory research and should not be used on humans or animals.
Attorney General Marshall said, “President Trump took decisive action to make GLP-1 weight-loss medications affordable and accessible to all Americans, ensuring that when prescribed responsibly and administered appropriately, these drugs can be an invaluable resource. By contrast, exploiting that demand by misrepresenting unapproved, research-only chemicals as legitimate medicine is one of the most dangerous forms of consumer deception imaginable.”
He added, “Patients who relied on this clinic were unknowingly injected with substances labeled strictly for research use, materials federal regulators have explicitly warned are risky for human use. This kind of reckless disregard for patient safety will not be tolerated in Alabama.”
The restraining order halts operations at Aurora IV and Wellness while legal proceedings continue. A preliminary injunction hearing is scheduled for November 13. The Attorney General seeks permanent restrictions preventing Amanda and Chris Medders from working in healthcare in Alabama, dissolution of their company, civil penalties, and restitution for consumers affected by the alleged conduct.
The Attorney General’s complaint alleges these actions began as early as May 2025. To help identify affected individuals, his office has created an online survey where patients who received tirzepatide or semaglutide injections from Aurora IV and Wellness since May 2025 can report their experiences through the Attorney General’s website.
Attorney General Marshall expressed appreciation to several agencies—including the Alabama Board of Nursing, Alabama Board of Medical Examiners, Cullman Police Department, and Winston County Sheriff’s Office—for assisting with both the investigation and execution of the court order.
